RESEARCHERS TARGET SIDE-EFFECTS OF QUITTING SMOKING TO DEVELOP NEW MEDICINES
April 1st, 2011
BY KEITH NUTHALL
EUROPEAN Union (EU) scientists are developing targeted anti-smoking medicines avoiding side-effects such as sleeplessness and muscle problems. The EU's NEUROCYPRES project has focused on brain pathways called ion channels which are opened and shut by certain chemicals. These can promote nicotine addiction, as well as sleep and muscle difficulties. So by understanding how to manipulate them, scientists hope to create smart drugs targeting one channel without negatively affecting others. Participant Professor Prof Dr Chris Ulens, of Belgium's ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.